| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5703264 | American Journal of Ophthalmology | 2017 | 22 Pages |
Abstract
Vision gains achieved during the 3-year VISTA DME trial were maintained through M12 of the ENDURANCE extension study with a reduced treatment frequency, with 30% of patients receiving no IAIs. No significant reduction in IAI frequency was observed after macular laser application.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Charles C. Wykoff, Ryan T. Le, Rahul N. Khurana, David M. Brown, William C. Ou, Rui Wang, W. Lloyd Clark, David S. Boyer, ENDURANCE Study Group ENDURANCE Study Group,